Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Clinical trial NCT05780905 · RECRUITING

Trial details

NCT number: NCT05780905
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Stroke (CVA) or Transient Ischemic Attack

Start date: 2024-01-11
Primary completion: 2026-03-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.